Abstract
Interleukin-6 (IL-6) interacts with a system of receptors, which include a 80-kDa IL-6-binding subunit (IL-6R) and a transducing element (gp130). The soluble form of IL-6R (sIL-6R) can bind its ligand and induce cellular responses by association with gp130, thus acting as an IL-6 agonist. We and others have previously shown that the responsiveness to IL-6 is different in hepatoma and human primary hepatocytes. We therefore compared the effects of sIL-6R on the two types of cells, and on the B9 hybridoma, another IL-6-sensitive cell line. Human primary hepatocytes, hepatoma cells PLC/PRF/5, and B9 cells were incubated with different concentrations of IL-6, sIL-6-R, or both. The hepatocyte culture supernatants were tested for their content of acute-phase proteins (APP). The proliferation of B9 cells was assessed by a colorimetric method. Results showed that sIL-6R alone markedly increased the production of APP by hepatoma cells in a dose-dependent manner, but affects only minimally primary hepatocytes and the proliferation of B9 cells. The combinations of IL-6R and its ligand enhanced the effects of Il-6 alone in both PLC/PRF/5 and B9 cells, but had no effect on primary hepatocytes. An immunohistochemical study indicated that the...Continue Reading
References
Jan 1, 1976·Methods in Cell Biology·P O Seglen
Jul 20, 1992·FEBS Letters·A MackiewiczP C Heinrich
Oct 23, 1992·Science·T KishimotoT Taga
Nov 1, 1992·Clinical and Experimental Immunology·J W Smith, T L McDonald
Sep 13, 1991·Journal of Immunological Methods·N W RoehmA L Glasebrook
Feb 1, 1991·Hybridoma·D NovickM Rubinstein
May 31, 1990·European Journal of Biochemistry·S Rose-JohnP C Heinrich
Oct 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·J GauldieH Baumann
Nov 25, 1988·Nucleic Acids Research·M Wilkinson
Aug 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·R M GrossmanA B Gottlieb
Oct 1, 1989·The Journal of Experimental Medicine·D NovickM Rubinstein
Mar 30, 1984·Journal of Immunological Methods·J Highton, P Hessian
Aug 1, 1994·Journal of Immunological Methods·M DiamantK Bendtzen
Aug 1, 1994·European Journal of Immunology·S HoriuchiN Yamamoto
May 1, 1994·The Journal of Clinical Investigation·F De BenedettiA Martini
Jan 1, 1993·Advances in Immunology·S AkiraT Kishimoto
Feb 1, 1993·European Journal of Immunology·J MüllbergS Rose-John
Apr 1, 1993·European Journal of Immunology·J P GaillardB Klein
May 1, 1993·European Journal of Immunology·H SuzukiT Kishimoto
Citations
Mar 1, 1997·The Journal of Pathology·H Moshage
Mar 27, 2001·European Journal of Immunology·J BrochierB Klein
Sep 9, 1996·Journal of Immunological Methods·B OppmannS Rose-John
May 19, 1997·FEBS Letters·V ThibaultJ Gauldie
Oct 31, 2001·Molecular Immunology·C P CoyneB W Fenwick
Aug 3, 1999·Matrix Biology : Journal of the International Society for Matrix Biology·P A GuerneJ M Dayer
Feb 28, 2002·The European Journal of Neuroscience·J C BensadounN Déglon
Nov 21, 1998·Immunology·S HoriuchiN Yamamoto
Jul 8, 2000·Kidney International·B MemoliG Rossi
Jan 9, 2013·The Journal of Biological Chemistry·Sun Wook ChoLaurie K McCauley
Jun 15, 1997·The Journal of Clinical Investigation·C GabayW P Arend
Jun 19, 2008·Arthritis Research & Therapy·Josef S SmolenOswald Wagner
Mar 1, 2000·Journal of Neuroimmunology·N J Van Wagoner, E N Benveniste
Sep 21, 2001·Cytokine·M WeiM Tarkka
Aug 22, 2001·The Journal of General Virology·C BenzH Hengel
Oct 3, 2012·PloS One·Siamak DjafarzadehStephan M Jakob
Sep 13, 2005·Developmental and Comparative Immunology·Norihisa NishimichiHaruo Matsuda
Jul 9, 2008·Scandinavian Journal of Gastroenterology·Othmar LudwiczekHerbert Tilg
Jun 5, 1998·The Journal of Biological Chemistry·P SilacciP A Guerne
Jan 8, 2021·Clinical Oral Investigations·C SchweitzerMarcela Hernández Rios